J. Erion

发表

Anticancer activity of targeted proapoptotic peptides.

B. Bernard, E. Krenning, A. Capello, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Phase 3 Trial of 177Lu‐Dotatate for Midgut Neuroendocrine Tumors

J. Berlin, E. Mittra, E. Van Cutsem, 2017, The New England journal of medicine.

Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer

E. Krenning, M. Jong, J. Erion, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Evaluation of a radiolabeled cyclic DTPA-RGD analog for tumor imaging and radionuclide therapy

B. Bernard, E. Krenning, M. Jong, 2000 .

Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.

T. Visser, B. Bernard, E. Krenning, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[177Lu‐DOTA0,Tyr3]octreotate for somatostatin receptor‐targeted radionuclide therapy

B. Bernard, E. Krenning, W. Breeman, 2001, International journal of cancer.

Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma

E. Krenning, A. van der Lugt, W. Breeman, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides.

E. Krenning, W. Breeman, J. Erion, 2008, Nuclear medicine and biology.

Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo

J. Erion, J. Reubi, J. Bugaj, 1998, European Journal of Nuclear Medicine.

Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma

E. Krenning, J. Erion, M. de Jong, 2000, European Journal of Nuclear Medicine.

Identification of the soluble in vivo metabolites of indium-111-diethylenetriaminepentaacetic acid-D-Phe1-octreotide.

J. Erion, L. Bass, C. Anderson, 1998, Bioconjugate chemistry.

Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study

S. Severi, D. Metz, J. Berlin, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Patients With Somatostatin Receptor–Expressing Neuroendocrine Tumors: The First US Phase 2 Experience

L. Kvols, E. Krenning, J. Erion, 2014, Pancreas.

Comparison of 1!1In-labeled Somatostatin Analogues for Tumor Scintigraphy and Radionuclide Therapy1

Willem, Helmut, Ananth, 2006 .

Comparison of 1 ! 1 In-labeled Somatostatin Analogues for Tumor Scintigraphy and Radionuclide Therapy 1

Joseph, Willem, Helmut, 2006 .

Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy.

B. Bernard, E. Krenning, A. Capello, 2004, Cancer biotherapy & radiopharmaceuticals.

DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy.

Joonyoung Kim, Jason S. Lewis, J. Erion, 2002, Bioconjugate chemistry.

Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.

S. Achilefu, J. Erion, J. Bugaj, 2003, Journal of medicinal chemistry.

Toxicity and dosimetry of 177Lu‐DOTA‐Y3‐octreotate in a rat model

R. Laforest, J. Lewis, J. Erion, 2001, International journal of cancer.

Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).

Jason S. Lewis, J. Erion, M. de Jong, 2007, Bioconjugate chemistry.

Radiotherapeutic efficacy of 153Sm-CMDTPA-Tyr3-octreotate in tumor-bearing rats☆

J. Erion, J. Bugaj, Michelle A. Schmidt, 2001 .

The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity

T. Visser, B. Bernard, E. Krenning, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Characterization of a radiolabeled small molecule targeting leukocyte function-associated antigen-1 expression in lymphoma and leukemia.

R. Larson, C. Wagner, J. Erion, 2006, Cancer biotherapy & radiopharmaceuticals.

The Current Status of Cytokinin-Binding Moieties

J. Erion, P. Keim, J. Fox, 1981 .

Five Stabilized 111In-labeled neurotensin analogs in nude mice bearing HT29 tumors.

B. Bernard, E. Krenning, W. Breeman, 2007, Cancer biotherapy & radiopharmaceuticals.

Purification and Properties of a Protein Which Binds Cytokinin-active 6-Substituted Purines.

J. Erion, J. Fox, J. Fox, 1981, Plant physiology.

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate

E. P. Krenning, W. H. Bakker, E. Krenning, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

A new intermediate in the synthesis of a tritiated cytokinin with high specific activity

J. Erion, J. Mcchesney, J. Fox, 1979 .

Isolation and characterization of a tomato Acid phosphatase complementary DNA associated with nematode resistance.

J. Erion, T. Fox, J. Bussell, 1991, Plant physiology.

Cytokinin-Binding Proteins in Higher Plants

J. Erion, J. Fox, 1977 .

A cytokinin binding protein from higher plant ribosomes.

J. Erion, J. Fox, 1975, Biochemical and biophysical research communications.

Ribosomal protein biosynthesis during starvation and refeeding in Tetrahymena pyriformis.

N. Brot, H. Weissbach, J. Erion, 1981, Archives of biochemistry and biophysics.

[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients

E. Krenning, J. Erion, M. de Jong, 2001, European Journal of Nuclear Medicine.

Therapy studies with [Lu-177]-DOTA-Y3-Octreotate in CA20948 tumor-implanted Lewis rats

J. Erion, J. Bugaj, Michelle A. Schmidt, 2000 .

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.

E P Krenning, E. Krenning, J. Erion, 2001, European journal of nuclear medicine.

Euglena gracilis chloroplast EF-Ts. Evidence that it is a nuclear-coded gene product.

N. Brot, H. Weissbach, J. Erion, 1980, The Journal of biological chemistry.

Synthesis of the large subunit of ribulose-1,5-bisphosphate carboxylase in anin vitro partially definedE. coli system

N. Brot, H. Weissbach, J. Erion, 1983, Plant Molecular Biology.

Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities

Marion de Jong, Wouter A. P. Breeman, T. Visser, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

E P Krenning, T. Visser, B. Bernard, 1998, Cancer research.

Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours

E. Krenning, M. Jong, J. Erion, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Are GRP-receptors present in the human pancreas?

E. Krenning, M. Jong, J. Erion, 2006 .

[DOTA,Tyr3]octreotate, labeled with 177Lu, is most promising for radionuclide therapy of somatostatin receptor-positive tumors

B. Bernard, E. Krenning, M. Jong, 2000 .

Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.

Samuel Achilefu, Raghavan Rajagopalan, Richard B Dorshow, 2002, Journal of medicinal chemistry.

Characterization of the mRNA transcripts of the maize, ribulose-1,5-bisphosphate carboxylase, large subunit gene

J. Erion, 1985, Plant Molecular Biology.

Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Patients With Somatostatin Receptor–Expressing Neuroendocrine Tumors: The First US Phase 2 Experience

L. Kvols, E. Krenning, J. Erion, 2014, Pancreas.

Cloning, mapping, and in vitro transcription-translation of the gene for the large subunit of ribulose-1,5-bisphosphate carboxylase from spinach chloroplasts.

N. Brot, H. Weissbach, J. Erion, 1981, Proceedings of the National Academy of Sciences of the United States of America.